Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT01434134

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01434134
Other papers using this trial's data
  • Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study Journal of the American Heart Association, 2017-11-08 DOI, PubMed 29118031, PMC5721750 In the PMC Open Access subset under CC BY-NC-ND.
  • Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol Circulation, 2021-06-22 DOI, PubMed 33993702, PMC8212877 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Norway (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01434134. Randomized; quadruple masking; primary purpose prevention. Start 2011-09 (registry gives no type); primary completion 2014-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
Acronym
PRADA
Condition
Breast Cancer
Condition
Heart Failure
Intervention (Drug)
Metoprolol
Intervention (Drug)
Placebo
Intervention (Drug)
Candesartan
Intervention (Drug)
Placebo
Lead sponsor
University Hospital, Akershus (class: other)
Collaborator
University of Oslo (class: other)
Collaborator
Norwegian Cancer Society (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01434134
Content hash
1f2a879ef76f0c48c416a05bebd304e1996566555bb4291d1b035a04b484f917